Heparin kinetics: Variables related to disposition and dosage
暂无分享,去创建一个
E. Haus | R. Cipolle | R. Seifert | D. Zaske | B. Neilan | E. Haus
[1] S. Gitel,et al. Heparin: new concepts relevant to clinical use. , 1979, Blood.
[2] T. Simon,et al. Heparin Pharmacokinetics: Increased Requirements in Pulmonary Embolism , 1978, British journal of haematology.
[3] C. Dollery,et al. Heparin Kinetics in Venous Thrombosis and Pulmonary Embolism , 1976, Circulation.
[4] J. Estes. The fate of heparin in the body. , 1975, Current therapeutic research, clinical and experimental.
[5] J. Hirsh,et al. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. , 1972, The New England journal of medicine.
[6] J. Estes. The heterogeneity of the anticoagulant response to heparin , 1972, Journal of clinical pathology.
[7] L. Armstrong,et al. Control of Heparin Therapy , 1970, Lancet.
[8] J. Hirsh,et al. HEPARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE: ADMINISTRATION, CONTROL AND RESULTS , 1968, The Medical journal of Australia.